ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...

Experimental therapy helped patients lose weight while improving blood sugar control, knee osteoarthritis pain and ...

HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% ...

Among 537 adults, average change from baseline in HbA1c concentration was -1.69% with retatrutide 4 mg, -1.86% with 9 mg, and ...

A large proportion of people living with type 2 diabetes treated with basal insulin therapy remain inadequately controlled ...

Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.

First-ever type 2 diabetes and obesity phase 3 study results for retatrutide, a novel glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1(GLP-1), and glucagon triple hormone ...

A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...

Today millions of diabetic patients across the world do not have access to insulin. Why and how can governments reverse this ...

Research suggests that eating more avocado may help reduce your risk of diabetes, lower blood pressure, and reduce your risk ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

Learn how Apple Watch supports diabetes management with CGM glucose readings, Apple Health records, medication reminders, ...